Drugs in the Pipeline Intranasal RSV Vaccine Fast Tracked for Those Over 60 and Children Under 2 By Steve Duffy Publish Date May 25, 2022
News FDA Authorizes Direct-to-Consumer Test to Detect COVID-19, Influenza, and RSV By Brian Park, PharmD Publish Date May 17, 2022
Generics News Pirfenidone Tablets Now Available for Idiopathic Pulmonary Fibrosis By Diana Ernst, RPh Publish Date May 13, 2022
News Inhaled Nitric Oxide Tied to Improved P/F Ratio in COVID-19 With ARDS Publish Date April 25, 2022
Drugs in the Pipeline Inhaled Therapy Gets Breakthrough Designation for Non-Cystic Fibrosis Bronchiectasis By Brian Park, PharmD Publish Date April 21, 2022
News New Law Allows FDA to Police E-Cigarettes Made With Synthetic Nicotine Publish Date April 18, 2022
Drugs in the Pipeline Efzofitimod Granted Orphan Drug Status for Systemic Sclerosis By Brian Park, PharmD Publish Date April 13, 2022
Drugs in the Pipeline Sabizabulin Cuts COVID-19 Death; Trial Stopped Early Due to Efficacy By Brian Park, PharmD Publish Date April 11, 2022
Drugs in the Pipeline Tocilizumab Gets Priority Review for Treatment of Hospitalized COVID-19 Patients By Brian Park, PharmD Publish Date April 5, 2022
Drugs in the Pipeline March 2022: Drug Pipeline Updates By Brian Park, PharmD Publish Date April 4, 2022
Drugs in the Pipeline RSV Vaccine Candidate for Older Adults Gets Breakthrough Therapy Designation By Brian Park, PharmD Publish Date March 25, 2022
News Losartan Does Not Reduce Lung Injury in Hospitalized COVID-19 Patients Publish Date March 17, 2022
Generics News First Generic Version of Symbicort Gets FDA Approval By Brian Park, PharmD Publish Date March 16, 2022